Enhanced Care for Smoking, Cessation
Study Summary
This study is evaluating whether a program which helps patients quit smoking will be effective in psychiatric patients.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: Assessed 6-weeks post-discharge
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Basic Care Condition
1 of 2
Enhanced Care Condition
1 of 2
Active Control
Experimental Treatment
1122 Total Participants · 2 Treatment Groups
Primary Treatment: Enhanced Care · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 4th, 2021
Last Reviewed: November 8th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.